Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection-Reference-Cited by-同舟云学术

Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection

Published:2015-02-24 Issue:1 Volume:62 Page:40-46
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Barone Michele¹,Notarnicola Antonella²,Lopalco Giuseppe²,Viggiani Maria Teresa³,Sebastiani Francesco³,Covelli Michele²,Iannone Florenzo²,Avolio Alfonso W.⁴,Di Leo Alfredo³,Cantarini Luca⁵,Lapadula Giovanni²

Affiliation:

1. Gastroenterology Unit, Department of Medical and Surgical SciencesUniversity of FoggiaFoggia Italy

2. Rheumatology Unit, Medical SchoolUniversity of BariBari Italy

3. Gastroenterology Unit, Department of Emergency and Organ TransplantationUniversity of BariBari Italy

4. Department of Surgery–Transplantation ServiceCatholic University of RomeRome Italy

5. Rheumatology Unit, Department Research Center of Systemic Autoimmune and Autoinflammatory DiseasesUniversity of SienaSiena Italy

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.27716

Reference36 articles.

1. A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

2. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

3. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

4. Assessing the safety of biologic agents in patients with rheumatoid arthritis

5. The role of tocilizumab in the management of rheumatoid arthritis

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis;Liver International;2024-08-29

2. Rituximab carries high risks of hepatitis B virus reactivation in hematologic and rheumatic patients with chronic or resolved hepatitis B;Journal of Gastroenterology and Hepatology;2024-08-24

3. ÇÖZÜLMÜŞ HEPATİT B ENFEKSİYONLU VE ROMATİZMAL HASTALIĞI OLAN BİREYLERDE RİTUKSİMAB KULLANIMININ HEPATİT B REAKTİVASYONU ÜZERİNE ETKİSİ: TEK MERKEZLİ BİR ÇALIŞMA;İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi;2024-06-20

4. Updates on the mechanisms of toxicities associated with monoclonal antibodies targeting growth factor signaling and immune cells in cancer;Toxicological Research;2024-04-22

5. Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy;Drug Safety;2024-02-14